Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
International Immunopharmacology|May 31, 2020
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectivesHilal Ahmed Parray, Shivangi Shukla, Sweety Samal, et al.
Retrovirology|November 23, 2016
Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopesSupratik Das, Saikat Boliar, Nivedita Mitra, et al.
Journal of Medical Virology|October 4, 2025
Lycorine Inhibits Chandipura Virus Replication In VitroTanvi Agrawal, Shikha Singh, Gurleen Kaur, et al.
3 Biotech|September 4, 2023
Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivityRitika Khatri, Bharat Lohiya, Gurleen Kaur, et al.
Journal of Virology|July 12, 2013
Mutations in the cytoplasmic domain of the Newcastle disease virus fusion protein confer hyperfusogenic phenotypes modulating viral replication and pathogenicitySweety Samal, Sunil K Khattar, Anandan Paldurai, et al.
Plos One|October 8, 2013
Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vectorSunil K Khattar, Sweety Samal, Celia C LaBranche, et al.
Human Vaccines & Immunotherapeutics|January 30, 2026
Pentameric M2e influenza vaccine candidate generates strong immunity with limited survival benefitVarun Kumar, Preeti Vishwakarma, Sneha Raj, et al.
Biochimica Et Biophysica Acta. General Subjects|September 19, 2020
Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loopShubbir Ahmed, Tripti Shrivastava, Rajesh Kumar, et al.
Biochemical and Biophysical Research Communications|July 14, 2024
Inhibition of early RNA replication in Chikungunya and Dengue virus by lycorine: In vitro and in silico studiesTanvi Agrawal, Gazala Siddqui, Ridhima Dahiya, et al.
Human Vaccines & Immunotherapeutics|February 20, 2015
Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virusSunil K Khattar, Senthilkumar Palaniyandi, Sweety Samal, et al.
Pageof 6